Clinical Trial Update: Long Term Safety and Efficacy of Fixed Dose Combination GSP 301 Nasal Spray (NS) in the Treatment of Perennial Allergic Rhinitis (PAR) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety and efficacy of fixed-dose combination GSP 301 nasal spray for perennial allergic rhinitis has completed with posted r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis

Drugs mentioned

• GSP 301 nasal spray

Snippet

Sponsor: Glenmark Specialty S.A. | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-13